Tumour escape from immune surveillance through dendritic cell inactivation

Seminars in Cancer Biology
Alain P VicariG Trinchieri

Abstract

Dendritic cells (DC) are central to the initiation of immunity. To induce immune reactivity, DC are recruited at the site of antigen expression, uptake antigens and migrate to secondary lymphoid organs while receiving activation signals delivered by pathogens, dying cells, and/or T cells. Tumours can escape the immune system by interfering with the migration of DC or by not providing the necessary activation signals. Moreover, tumours promote the secretion of factors that inhibit DC differentiation and functions. We will review the current knowledge of the physiopathology of DC in cancer, which paves the way for novel strategies of therapeutic intervention.

Citations

Dec 7, 2007·Archivum Immunologiae Et Therapiae Experimentalis·Paweł KrawczykJacek Roliński
Nov 10, 2007·Cell Death and Differentiation·E UllrichL Zitvogel
Jan 26, 2011·Proceedings of the National Academy of Sciences of the United States of America·Annie W Lau-KilbyKristin V Tarbell
Jul 28, 2009·Human Gene Therapy·Robin J PrestwichRichard G Vile
Aug 7, 2009·Human Gene Therapy·Evelien L J M SmitsViggo F I Van Tendeloo
Apr 29, 2008·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Jon R InglefieldJohn P Vasilakos
Jul 15, 2004·Science's STKE : Signal Transduction Knowledge Environment·Edgar G EnglemanLuis Soares
Feb 14, 2006·Journal of Virology·Maryam AhmedElizabeth M Hiltbold
Nov 24, 2011·Clinical & Developmental Immunology·Nona JanikashviliNicolas Larmonier
Mar 11, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elizabeth J IlettAlan A Melcher
Mar 3, 2004·The Journal of Clinical Investigation·Katsuyoshi FurumotoMiriam Merad
Nov 13, 2013·The Journal of Clinical Investigation·C Andrew StewartGiorgio Trinchieri
Jul 19, 2013·The Journal of Clinical Investigation·Anusha KalbasiNeha Vapiwala
May 2, 2012·BMC Bioinformatics·Giulio CaravagnaAlberto d'Onofrio
Mar 21, 2013·Critical Reviews in Immunology·Neale HankeNicolas Larmonier
Feb 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Farhad Haghighi RadGeorges Uzan
Nov 8, 2013·BioMed Research International·Mohammad Zahid KamranRajiv P Gude
May 29, 2008·Molecular Cancer Research : MCR·Emily C Brantley, Etty N Benveniste
Feb 6, 2010·Expert Opinion on Biological Therapy·E J IlettA A Melcher
Sep 15, 2015·Oncogene·J C RoeserF McAllister
Jun 13, 2006·Scandinavian Journal of Immunology·P-J RoyerM Gregoire
May 4, 2011·Journal of Experimental & Clinical Cancer Research : CR·Jianfeng ZhengXiaozhong Wang
Oct 18, 2011·Immunopharmacology and Immunotoxicology·Aws Alshamsan
Jan 6, 2012·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·H-G ZhangW E Grizzle
Nov 20, 2012·Oncoimmunology·Alison M McDonnellBruce W S Robinson
Nov 22, 2012·Oncoimmunology·Lorenzo GalluzziGuido Kroemer
Oct 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roger K StrairEdmund C Lattime
Sep 28, 2007·Nature·Ralph M Steinman, Jacques Banchereau
May 12, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Chiara BrignoleMirco Ponzoni
Dec 1, 2014·Surgical Pathology Clinics·Marc P PusztaszeriPeter M Sadow
Jan 13, 2018·Journal of Cellular Biochemistry·Shishir UpadhyayMonisha Dhiman
Jan 18, 2018·Cancer Immunology, Immunotherapy : CII·Lucas BaslerStephan M Huber
Jun 16, 2004·International Journal of Cancer. Journal International Du Cancer·Masaki IrieGotaro Toda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.